跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
PREGABALIN SANDOZ CAPSULES 150MG - HSA Drug Approval Details
Approvals
/
HSA
/
PREGABALIN SANDOZ CAPSULES 150MG
Approved
THERAPEUTIC
PREGABALIN SANDOZ CAPSULES 150MG
GENVEON ILAC SANAYI VE TICARET A.S. - TURKEYSALUTAS PHARMA GMBH (GERMANY)
🇸🇬 Health Sciences Authority
Approval Date
Nov 10, 2017
Approval ID
8afdcc2a985ee74b
Company
GENVEON ILAC SANAYI VE TICARET A.S. - TURKEYSALUTAS PHARMA GMBH (GERMANY)
Type
Therapeutic
Approval Details
Approval Id
8afdcc2a985ee74b
Drug Name
PREGABALIN SANDOZ CAPSULES 150MG
Product Name
PREGABALIN SANDOZ CAPSULES 150MG
Approval Number
SIN15358P
Approval Date
2017-11-10
Registrant
SANDOZ SINGAPORE PTE. LTD.
Licence Holder
SANDOZ SINGAPORE PTE. LTD.
Drug Type
Therapeutic
Forensic Classification
PRESCRIPTION ONLY MEDICINES
Dosage Form
CAPSULE
Route Of Administration
ORAL
Atc Code
N03AX16
Atc Item Name
xn 03 ax 16
Pharma Manufacturer Name
SANDOZ SINGAPORE PTE. LTD.
Company Detail Path
/organization/sandoz-singapore-pte-ltd
Active Ingredients
PREGABALIN
150mg
PREGABALIN
150 MG
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Nov 10, 2017
Approval ID
8afdcc2a985ee74b
Type
Therapeutic
Back to HSA Approvals